본문 바로가기

Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY68(5) · pp.657 · 2012
피인용
Web of Science 36
JCR IF
JCR 2011 2.845
ISSN
0031-6970

저자

  1. Kim, In-Wha서울대학교, Pharmaceut Sci Res Inst, KO
  2. Moon, Yoo Jin서울대학교, Pharmaceut Sci Res Inst, KO
  3. Ji, Eunhee서울대학교, Pharmaceut Sci Res Inst, KO
  4. Kim, Kyung Im서울대학교, Pharmaceut Sci Res Inst, KO
  5. Han, Nayoung서울대학교, Pharmaceut Sci Res Inst, KO
  6. Kim, Sung Ju고려대학교, Dept Stat, KO
  7. Shin, Wan Gyoon서울대학교, Pharmaceut Sci Res Inst, KO
  8. Ha, Jongwon서울대학교, Coll Med, Dept Surg, KO
  9. 윤정현부산대학교, 약학대학, 약학부, 약학전공, KO
  10. Lee, Hye Suk서울대학교, Dept Pharm, KO
  11. Oh, Jung Mi서울대학교, Pharmaceut Sci Res Inst, KO

초록

The purpose of this study was to characterize the effects of clinical and genetic variables on the pharmacokinetics and complications of tacrolimus during the first year after kidney transplantation. One hundred and thirty-two Korean kidney recipients who received tacrolimus were genotyped for ABCB1 (exons 12, 21, and 26) and CYP3A5 (intron 3). Tacrolimus trough levels, dose, or dose-adjusted trough levels and complications were compared among patients during the early stage (3, 7, 14, 30, and 90 days) and up to 1 year according to the genotypes. A donor source-adjusted linear mixed model with multilevel analysis adjusting for age, body weight, hematocrit, and serum creatinine showed that CYP3A5 genotype is associated with dose-adjusted level of tacrolimus (p < 0.001). The influence of ABCB1 polymorphisms on the pharmacokinetics or complications of tacrolimus was less certain in our study. The incidence of acute rejections was significantly higher in recipients of cadaveric donor kidney (p < 0.05). A generalized estimating equation model analysis showed that alopecia and hyperlipidemia were associated with dose-adjusted level of tacrolimus (p < 0.001). Genotype of CYP3A5 variants along with significant clinical covariates may be useful in individualizing tacrolimus therapy in kidney transplantation patients.

키워드

TacrolimusPolymorphismPharmacogeneticsKidneyTransplantationACUTE REJECTIONRENAL-TRANSPLANTATIONABCB1 POLYMORPHISMSDOSE REQUIREMENTSSERUM CREATININECYP3A5PHARMACOKINETICSCYCLOSPORINEBLOODFK506

식별자

WoS UID
000303452800022